The conjugation of Gd(III) complexes with PSMA-targeting ligands to AuNP surfaces leads to enhanced uptake of AuNPs by PSMA-expressing cancer cells, with excellent MRI contrast and radiation therapy outcomes in vivo and in vitro. The gene discussed is FOLH1; the disease is cancer.